Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upSibylle Loibl, Nadia Harbeck, Meredith M. Regan et al.|Annals of Oncology|2023Cited by 830
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumoursC. Coyle, Ruth E. Langley, Fay Cafferty et al.|Contemporary Clinical Trials|2016Cited by 162
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trialNalinie Joharatnam‐Hogan, R. Steele, Fay Cafferty et al.|The Lancet. Gastroenterology & hepatology|2019Cited by 64
Breast cancer in a tertiary cancer center in India - An audit, with outcome analysisTanuja Shet, Rajendra Badwe, Nita Nair et al.|Indian Journal of Cancer|2018Cited by 52
Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in IndiaJyoti Bajpai, Rajendra Badwe, Pradeep Ventrapati et al.|The Breast|2021Cited by 39